Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
17 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//MICROBIOLOGY//JOURNAL OF BACTERIOLOGY | 725599 |
222 | 3 | AQUEOUS TWO PHASE SYSTEMS//CORYNEBACTERIUM GLUTAMICUM//BIOCHEMISTRY & MOLECULAR BIOLOGY | 49487 |
2603 | 2 | ALANINE RACEMASE//PYRIDOXAL 5 PHOSPHATE//TYROSINE PHENOL LYASE | 3867 |
21990 | 1 | 4 AMINOBUTYRATE AMINOTRANSFERASE//GAMMA AMINOBUTYRIC ACID AMINOTRANSFERASE//GABA AT | 421 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | 4 AMINOBUTYRATE AMINOTRANSFERASE | authKW | 823470 | 3% | 100% | 11 |
2 | GAMMA AMINOBUTYRIC ACID AMINOTRANSFERASE | authKW | 532342 | 2% | 89% | 8 |
3 | GABA AT | authKW | 366814 | 2% | 70% | 7 |
4 | 3 HYDROXYISOBUTYRATE DEHYDROGENASE | authKW | 333466 | 2% | 64% | 7 |
5 | HIBCH | authKW | 224583 | 1% | 100% | 3 |
6 | SERINE DEHYDROGENASE | authKW | 224583 | 1% | 100% | 3 |
7 | D 3 AMINOISOBUTYRATE PYRUVATE AMINOTRANSFERASE | authKW | 168435 | 1% | 75% | 3 |
8 | 3 HYDROXYISOBUTYRIC ACIDURIA | authKW | 149722 | 0% | 100% | 2 |
9 | BETA ALANINE OXOGLUTARATE AMINOTRANSFERASE | authKW | 149722 | 0% | 100% | 2 |
10 | GABA AT INHIBITOR | authKW | 149722 | 0% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1168 | 44% | 0% | 187 |
2 | Chemistry, Organic | 725 | 20% | 0% | 83 |
3 | Chemistry, Medicinal | 640 | 12% | 0% | 51 |
4 | Biophysics | 252 | 10% | 0% | 41 |
5 | Genetics & Heredity | 55 | 6% | 0% | 26 |
6 | Medicine, Research & Experimental | 55 | 5% | 0% | 23 |
7 | Chemistry, Multidisciplinary | 48 | 10% | 0% | 42 |
8 | Biochemical Research Methods | 30 | 4% | 0% | 16 |
9 | Endocrinology & Metabolism | 18 | 4% | 0% | 16 |
10 | Pharmacology & Pharmacy | 12 | 6% | 0% | 25 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIO OURCE SCI PL MICROBIOL | 74861 | 0% | 100% | 1 |
2 | BIO OURCE SCI PL MICROBIOL NANKO KU | 74861 | 0% | 100% | 1 |
3 | CLIN GENOM PREDICT MED | 74861 | 0% | 100% | 1 |
4 | DIPARTIMENTO SCI BIOCHIM PIAZZALE ALDO MORO 5 | 74861 | 0% | 100% | 1 |
5 | EMIL ERLENMEYER FORUM | 74861 | 0% | 100% | 1 |
6 | GENET PEDIATKING ABDULAZIZ MED CITY | 74861 | 0% | 100% | 1 |
7 | HEAD GENET METAB DIS | 74861 | 0% | 100% | 1 |
8 | HOSP NEUROL SURG | 74861 | 0% | 100% | 1 |
9 | RADBOUD MITOCHONDRIAL MED TRANSLAT METAB | 74861 | 0% | 100% | 1 |
10 | SOZIALPADIATR ZENTRUM NEUROPADIATRIE | 74861 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF ENZYME INHIBITION | 5247 | 1% | 1% | 5 |
2 | JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY | 1795 | 2% | 0% | 8 |
3 | PRZEMYSL CHEMICZNY | 1441 | 2% | 0% | 10 |
4 | SEIZURE | 1225 | 0% | 2% | 1 |
5 | SYNTHETIC COMMUNICATIONS | 1160 | 4% | 0% | 15 |
6 | JOURNAL OF INHERITED METABOLIC DISEASE | 1037 | 2% | 0% | 8 |
7 | BIOORGANIC & MEDICINAL CHEMISTRY | 785 | 3% | 0% | 12 |
8 | JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 627 | 0% | 1% | 1 |
9 | EUROPEAN JOURNAL OF BIOCHEMISTRY | 621 | 3% | 0% | 13 |
10 | JOURNAL FUR PRAKTISCHE CHEMIE-PRACTICAL APPLICATIONS AND APPLIED CHEMISTRY | 603 | 0% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |